Compare PHR & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHR | OMDA |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | 868 |
| Industry | Business Services | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.2M | 711.1M |
| IPO Year | 2019 | N/A |
| Metric | PHR | OMDA |
|---|---|---|
| Price | $12.66 | $13.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $30.65 | $24.30 |
| AVG Volume (30 Days) | ★ 2.0M | 1.2M |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.36 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $419,813,000.00 | N/A |
| Revenue This Year | $15.56 | $52.49 |
| Revenue Next Year | $15.08 | $22.68 |
| P/E Ratio | $619.75 | ★ N/A |
| Revenue Growth | ★ 17.83 | N/A |
| 52 Week Low | $11.31 | $10.28 |
| 52 Week High | $32.76 | $26.92 |
| Indicator | PHR | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 44.82 | 55.83 |
| Support Level | $11.44 | $10.28 |
| Resistance Level | $12.79 | $16.93 |
| Average True Range (ATR) | 0.66 | 0.81 |
| MACD | 0.22 | 0.36 |
| Stochastic Oscillator | 85.99 | 93.79 |
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.